Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

UC Davis Transdermal Lidocaine Tinnitus Study

Also known as: Transdermal Lidocaine, 5% Commercially Available Transdermal Lidocaine, Commercial Lidocaine Patch as a Treatment for Ear-ringing, NCT02088866

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Small Molecule

Stage

Early Phase 1

Status

Completed

Target Gene

—

Route / Mode

Transdermal patch

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

United States

Population

adult, tinnitus

Trial IDs

Mechanism

Completed early Phase 1 academic study of commercially available 5% transdermal lidocaine patches for tinnitus.

Indications

Tinnitus

Notes

Verified as a completed UC Davis exploratory lidocaine-patch tinnitus study. It should be shown as a historical academic generic-repurposing study, not as an active product program.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT02088866

Open

Key Events

2014-03-01

Registry lists study start for transdermal lidocaine tinnitus study

2015-09-01

Registry lists actual completion of transdermal lidocaine tinnitus study

Clinical Trials (1)